[1] |
HAN Xue-fei;GUO Ying;ZHANG Hong;YAN Yan;XUE Shou-ru.
Clinical observation of immunomodulatory treatments for myasthenia gravis
[J]. CLINICAL FOCUS, 2013, 28(12): 1355-1357.
|
[2] |
.
[J]. Clinical Focus, 2012, 27(22): 1999-0.
|
[3] |
.
[J]. CLINICAL FOCUS, 2010, 25(17): 1548-0.
|
[4] |
YU Ning;XIE Bing-di;AN Zhong-ping.
Neurophysiological abnormalities in myasthenia gravis with thymic hyperplasia and thymoma
[J]. CLINICAL FOCUS, 2010, 25(2): 115-118.
|
[5] |
.
[J]. CLINICAL FOCUS, 2009, 24(10): 868-0.
|
[6] |
.
[J]. CLINICAL FOCUS, 2009, 24(2): 182-184.
|
[7] |
.
[J]. CLINICAL FOCUS, 2008, 23(18): 1348-0.
|
[8] |
.
[J]. CLINICAL FOCUS, 2008, 23(12): 843-843.
|
[9] |
.
[J]. CLINICAL FOCUS, 2008, 23(5): 363-363.
|
[10] |
.
[J]. CLINICAL FOCUS, 2008, 23(1): 30-31.
|
[11] |
.
[J]. CLINICAL FOCUS, 2006, 21(24): 1773-1774.
|
[12] |
.
[J]. CLINICAL FOCUS, 2006, 21(17): 1248-1249.
|
[13] |
.
[J]. CLINICAL FOCUS, 2006, 21(14): 996-996.
|
[14] |
.
[J]. CLINICAL FOCUS, 2005, 20(21): 1206-1206.
|
[15] |
.
[J]. CLINICAL FOCUS, 2005, 20(20): 1186-1186.
|